Erythrocyte transketolase activity in uremia

Area of Science:

• Biochemistry
• Clinical Nutrition
• Nephrology

Background:

• Thiamine (vitamin B1) is crucial for cellular energy metabolism.
• Erythrocyte transketolase (eTK) activity is a key indicator of thiamine status.
• Uremia is associated with metabolic disturbances and potential neurological complications.

Purpose of the Study:

• To investigate erythrocyte transketolase activity and thiamine metabolism in uremic patients.
• To explore the relationship between thiamine status, eTK activity, and uremic neuropathy.
• To determine if eTK inhibition contributes to the development of neuropathy in uremia.

Main Methods:

• Assessed erythrocyte transketolase activity and thiamine pyrophosphate (TPP) effect in 73 uremic patients and 67 controls.
• Measured total vitamin B1 levels in whole blood.
• Correlated eTK activity with TPP effect and vitamin B1 levels.
• Compared eTK activity between uremic patients with and without neuropathy.
• Examined correlation between eTK activity and motor nerve conduction velocity.

Main Results:

• Uremic patients had elevated whole blood vitamin B1 but lower eTK activity and TPP effect compared to controls.
• eTK activity correlated with TPP effect and vitamin B1 levels.
• Significant inhibition of eTK activity was observed in uremic patients.
• No significant difference in eTK activity was found between uremic patients with and without neuropathy.
• No direct correlation was confirmed between eTK activity and motor nerve conduction velocity.

Conclusions:

• Erythrocyte transketolase activity is inhibited in uremic patients, indicating altered thiamine metabolism.
• This inhibition alone does not appear to be the primary driver of uremic neuropathy.
• Further research is needed to elucidate the complex mechanisms underlying uremic neuropathy.